NOCTIVA
Peakdesmopressin acetate
NDANASALSPRAY, METERED
Approved
Mar 2017
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
1
Clinical Trials (1)
Desmopressin Acetate 0.2 mg Tablets, Fasting
Started Jul 2003
48 enrolled
Healthy
Loss of Exclusivity
LOE Date
Jun 15, 2030
52 months away
Patent Expiry
Jun 15, 2030